Healthcare Technologies signs up European distributors:
This article was originally published in Clinica
Israeli company Healthcare Technologies has signed two European distribution deals for its diagnostics tests. The agreements, made through its Savyon diagnostics subsidiary, are with BMD in France and Hain Diagnostika in Germany. BMD has signed a five year contract, with a commitment to order $583,000 of kits in the first year, while Hain has signed-up for three years with $457,000 of orders in the first year, reports Reuters.
You may also be interested in...
Biopharma was an attractive investment in 2020 and fundamentals are unchanged in 2021, including the pandemic’s work-at-home requirements, which allowed more companies to go public faster.
Abbott reported almost 28% revenue growth in the fourth quarter led by the exploding demand for COVID-19 tests and continued success of its FreeStyle Libre continuous glucose monitor.
While representing a smaller population, the ACTIVATE-T trial targeted patients seen as having greater unmet need.